Aberrant Hedgehog signaling underlies a variety of cancers, with notable examples being basal cell carcinoma and medulloblastoma.[10, 11] Cancers that are caused by loss‐of‐function mutations in PTCH1 are amenable to treatment with SMO inhibitors, such as the FDA‐approved drugs vismodegib and sonidegib. Here, SMO is linked to cancer.